dysport clostridium botulinum type a toxin
ipsen pty ltd - clostridium botulinum type a toxin haemagglutinin complex, quantity: 300 u - injection, powder for - excipient ingredients: albumin; lactose monohydrate - dysport is indicated for symptomatic treatment of focal spasticity of: ? upper limbs in adults ? lower limbs in adults ? upper limbs in children aged 2 years and older ? lower limbs in children aged 2 years and older,dysport is indicated in adults for the treatment of: ? spasmodic torticollis ? blepharospasm ? hemifacial spasm ? moderate to severe glabellar lines and / or lateral canthal lines (crow?s feet)
nutropin aq somatropin recombinant dna 10mg/2ml solution for injection cartridge
ipsen pty ltd - somatropin, quantity: 5 mg/ml - injection, solution - excipient ingredients: water for injections; phenol; polysorbate 20; sodium citrate dihydrate; citric acid; sodium chloride - long-term treatment of children with growth failure due to inadequate endogenous growth hormone secretion. long-term treatment of growth failure associated with turner syndrome. treatment of prepubertal children with growth failure associated with chronic renal insufficiency up to the time of renal transplantation. treatment of adults with severe growth hormone deficiency as diagnosed in the insulin tolerance test for growth hormone deficiency and defined by peak gh concentrations of less than 2.5 ng/ml.
somatuline la lanreotide 30mg (as acetate) powder for injection vial with diluent ampoule
ipsen pty ltd - lanreotide acetate -
azzalure, 125 speywood units, powder for solution for injection
ipsen pharma 65 quai georges gorse, 92100 boulogne-billancourt,, france - powder for solution for injection - botulinum toxin type a 125 u - muscle relaxants
medicine administration kit, percutaneous, medicated, single-use
ipsen pty ltd - 45156 - medicine administration kit, percutaneous, medicated, single-use - medical administration kit (needles and syringes).
somatuline autogel prolonged release solution for injection in a pre-filled syringe 120 mg
ipsen pharma singapore pte. ltd. - lanreotide acetate 149.4mg eqv lanreotide - injection, solution - 120 mg - lanreotide acetate 149.4mg eqv lanreotide 120 mg
somatuline autogel prolonged release solution for injection in a pre-filled syringe 60 mg
ipsen pharma singapore pte. ltd. - lanreotide acetate 77.9mg eqv lanreotide - injection, solution - 60 mg - lanreotide acetate 77.9mg eqv lanreotide 60 mg
somatuline autogel prolonged release solution for injection in a pre-filled syringe 90 mg
ipsen pharma singapore pte. ltd. - lanreotide acetate 113.6mg eqv lanreotide - injection, solution - 90 mg - lanreotide acetate 113.6mg eqv lanreotide 90 mg
diphereline p.r. powder and solvent for suspension for injection 3.75 mgvial
ipsen pharma singapore pte. ltd. - triptorelin acetate 4.9 mg eqv triptorelin - injection, powder, for suspension, extended release - 3.75 mg/vial - triptorelin acetate 4.9 mg eqv triptorelin 3.75 mg/vial
basic growth hormone pen, replaceable-cartridge
ipsen pty ltd - 46091 - basic growth hormone pen, replaceable-cartridge - subcutaneously inject a controlled dose of human growth hormone through a replaceable needle